Anika Therapeutics ANIK
NASDAQ ANIK
$19.10 -0.26 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Liabilities from Discontinued Operations (2023 - 2024)

Updated

Anika Therapeutics' Liabilities from Discontinued Operations was $659,000 in Q4 2024, down 33.4% from $989,000 a year earlier.

Analysis

Anika Therapeutics (ANIK) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

  • In earlier years, Liabilities from Discontinued Operations was $989,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Anika Therapeutics 255.62 Mn -10.93 Mn 21.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 659,000.00
Dec 31, 2023 989,000.00
API Access

Anika Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ANIK&period=max&api_key=YOUR_API_KEY